Ppe Net - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xeris Biopharma Holdings Inc
PP&E Net Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
PP&E Net
$28.7m
CAGR 3-Years
62%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
PP&E Net
$19.7B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
PP&E Net
$8.2B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
PP&E Net
$19B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
PP&E Net
$23.2B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
PP&E Net
$14.8B
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
6%

See Also

What is Xeris Biopharma Holdings Inc's PP&E Net?
PP&E Net
28.7m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's PP&E Net amounts to 28.7m USD.

What is Xeris Biopharma Holdings Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
30%

Over the last year, the PP&E Net growth was -5%. The average annual PP&E Net growth rates for Xeris Biopharma Holdings Inc have been 62% over the past three years , 30% over the past five years .

Back to Top